U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Name Type Language
GM-102
Preferred Name English
MURLENTAMAB
INN  
Official Name English
murlentamab [INN]
Common Name English
IMMUNOGLOBULIN G1, ANTI-(HUMAN ANTI-MUELLERIAN HORMONE RECEPTOR TYPE II) (HUMANIZED MONOCLONAL GM102 .GAMMA.1-CHAIN), DISULFIDE WITH HUMANIZED MONOCLONAL GM102 .KAPPA.-CHAIN, DIMER
Common Name English
GM102
Code English
Murlentamab [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 578617
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
Code System Code Type Description
INN
10858
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
PRIMARY
FDA UNII
ZN0DUZ3M4L
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
PRIMARY
CAS
2058047-65-5
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
PRIMARY
NCI_THESAURUS
C136985
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
PRIMARY
SMS_ID
100000183553
Created by admin on Wed Apr 02 01:27:08 GMT 2025 , Edited by admin on Wed Apr 02 01:27:08 GMT 2025
PRIMARY
ACTIVE MOIETY
MURLENTAMAB
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966